Risk factors for poor renal prognosis in children with hemolytic uremic syndrome
暂无分享,去创建一个
L. Ravà | G. Capasso | G. Ardissino | A. Edefonti | A. Caprioli | R. Coppo | G. Rizzoni | A. Tozzi | A. Bettinelli | M. Pennesi | G. Montini | R. Penza | F. Perfumo | G. Zacchello | L. Peratoner | G. Lama | S. Li Volti | S. Maringhini | A. Gianviti | N. Miglietti | C. Pecoraro | I. Pela | L. De Petris | E. Salvaggio | T. De Palo | A. Caringella | S. Maffei | M. Gaido | A. Ferretti | Ilse Ratsche | C. Setzu | Maurizio Gaido
[1] S. Ostroff,et al. Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Shiga-like toxin II, andEscherichia coli O157:H7 lipopolysaccharide in human serum , 1991, Current Microbiology.
[2] W. Proesmans,et al. Childhood haemolytic uraemic syndrome: Long-term outcome and prognostic features , 2005, European Journal of Pediatrics.
[3] P. Niaudet,et al. Haemolytic uraemic syndrome: prognostic factors in children over 3 years of age , 1995, Pediatric Nephrology.
[4] A. Caprioli,et al. Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy , 1994, Pediatric Nephrology.
[5] T. Barratt,et al. The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome , 1989, Pediatric Nephrology.
[6] A. Edefonti,et al. Shiga Toxin–Producing Escherichia coli Infections Associated with Hemolytic Uremic Syndrome, Italy, 1988–2000 , 2003, Emerging infectious diseases.
[7] M. Ciol,et al. Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. , 2002, The New England journal of medicine.
[8] P. Ray,et al. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome , 2001, Pediatric Nephrology.
[9] L. V. D. Heuvel,et al. Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. , 2001, Journal of the American Society of Nephrology : JASN.
[10] J. H. Green,et al. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. , 2001, The Journal of infectious diseases.
[11] F. Grimont,et al. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France , 2000, Epidemiology and Infection.
[12] H. Karch,et al. EnterohemorrhagicEscherichia coli (EHEC) in Pediatric Hemolytic-Uremic Syndrome: A Prospedtive Study in Germany and Austria* , 1999, Infection.
[13] J. Ehrich,et al. Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow , 1999, Pediatric Nephrology.
[14] C. Jenkins,et al. The serodiagnosis of infections caused by Verocytotoxin‐producing Escherichia coli , 1999, Journal of applied microbiology.
[15] G. Remuzzi,et al. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura. , 1999, Journal of the American Society of Nephrology : JASN.
[16] M. Kazatchkine,et al. Human complement factor H deficiency associated with hemolytic uremic syndrome. , 1998, Journal of the American Society of Nephrology : JASN.
[17] J. Goodship,et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. , 1998, Kidney international.
[18] A. Caprioli,et al. Enteroaggregative, Shiga Toxin-ProducingEscherichia coli O111:H2 Associated with an Outbreak of Hemolytic-Uremic Syndrome , 1998, Journal of Clinical Microbiology.
[19] A. Caprioli,et al. Non-O157 Shiga toxin-producing Escherichia coli infections in Europe. , 1997, Emerging infectious diseases.
[20] N. Bibiloni,et al. Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features , 1997, Pediatric Nephrology.
[21] R. Christofferson,et al. Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease. , 1996, The Journal of pediatrics.
[22] A. Caprioli,et al. Detection of serum antibodies to the lipopolysaccharide of Escherichia coli O103 in patients with hemolytic-uremic syndrome. , 1995, The Journal of infectious diseases.
[23] R. Christofferson,et al. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. , 1994, Pediatrics.
[24] A. Edefonti,et al. Communitywide Outbreak of Hemolytic-Uremic Syndrome Associated with Non-O157 Verocytotoxin-Producing Escherichia coli , 1994 .
[25] B. Tönshoff,et al. Outcome and prognostic determinants in the hemolytic uremic syndrome of children. , 1994, Nephron.
[26] A. Edefonti,et al. Plasma exchange in children with hemolytic-uremic syndrome at risk of poor outcome. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] T. Barratt,et al. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. , 1993, The Journal of pediatrics.
[28] A. Leung,et al. Relationship of the recovery in the glomerular filtration rate to the duration of anuria in diarrhea-associated hemolytic uremic syndrome. , 1993, American journal of nephrology.
[29] A. Caprioli,et al. Hemolytic-Uremic Syndrome and Vero Cytotoxin-Producing Escherichia coli Infection in Italy , 1992 .
[30] A. Morrow,et al. Association between severity of gastrointestinal prodrome and long-term prognosis in classic hemolytic-uremic syndrome. , 1992, The Journal of pediatrics.
[31] J. Kelton,et al. Comparison of Plasma Exchange With Plasma Infusion in the Treatment of Thrombotic Thrombocytopenia Purpura , 1992 .
[32] J. Kelton,et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. , 1991, The New England journal of medicine.
[33] A. Leung,et al. The successful treatment of atypical hemolytic uremic syndrome with plasmapheresis. , 1991, Clinical nephrology.
[34] L. Jorde,et al. Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome. , 1991, The Journal of pediatrics.
[35] R. Tauxe,et al. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. , 1991, Epidemiologic reviews.
[36] B. Rowe,et al. Changes in the postenteropathic form of the hemolytic uremic syndrome in children. , 1991, Clinical nephrology.
[37] T. Feest,et al. Haemolytic-uraemic syndrome with renal failure: the effect of plasmapheresis. , 1985, Haematologica.
[38] H. Lior,et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. , 1985, The Journal of infectious diseases.
[39] C. Loirat,et al. Hemolytic‐uremic Syndrome: An Analysis of the Natural History and Prognostic Features , 1984, Acta paediatrica Scandinavica.
[40] N. D. Kalmin,et al. Plasmapheresis in a child with the hemolytic‐uremic syndrome , 1983, Transfusion.
[41] T. Barratt,et al. Haemolytic-uraemic syndrome: an analysis of prognostic features. , 1983, Archives of disease in childhood.
[42] H. Thysell,et al. Successful treatment of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura with fresh frozen plasma and plasma exchange. , 2009, Acta medica Scandinavica.
[43] G. Carlos,et al. The hemolytic-uremic syndrome , 1964 .